Methylation of the promoter of dopamine receptor genes (DRD2, DRD3, and DRD4) also alters dopamine expression and causes cognitive deficits associated with SCZ (Cheng et al., 2014; Dai et al., 2014; Chen et al., 2020). This evidence concerns the gene DRD3 and Cognitive impairment.